Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
115M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
62.1M
-
Shares change
-
-3.53M
-
Total reported value, excl. options
-
$50.1M
-
Value change
-
-$6.46M
-
Put/Call ratio
-
0.67
-
Number of buys
-
49
-
Number of sells
-
-49
-
Price
-
$0.81
Significant Holders of Coherus Oncology, Inc. - Common Stock (CHRS) as of Q1 2025
137 filings reported holding CHRS - Coherus Oncology, Inc. - Common Stock as of Q1 2025.
Coherus Oncology, Inc. - Common Stock (CHRS) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.1M shares
of 115M outstanding shares and own 53.79% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (11.2M shares), BlackRock, Inc. (11M shares), Rubric Capital Management LP (5.26M shares), TANG CAPITAL MANAGEMENT LLC (5.1M shares), Kohlberg Kravis Roberts & Co. L.P. (3.04M shares), MILLENNIUM MANAGEMENT LLC (2.9M shares), GEODE CAPITAL MANAGEMENT, LLC (2.66M shares), STATE STREET CORP (2.23M shares), CM Management, LLC (2.15M shares), and C WorldWide Group Holding A/S (1.93M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.